Patients with Fabry disease after enzyme replacement therapy dose reduction versus treatment switch.
暂无分享，去创建一个
J. Stypmann | C. Wanner | F. Weidemann | C. Sommer | T. Duning | S. Störk | N. Üçeyler | M. Niemann | S. Brand | E. Brand | A. Krebs | S. Reiermann | J. Krämer | S. Canaan-kühl | M. Lenders | H. Guerrero González | Michael Schelleckes | Malte Lenders